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Abstract
Bordetella bronchiseptica is closely related with B. pertussis and B. parapertussis, the causative agents of whooping cough.
These pathogenic species share a number of virulence genes, including the gene locus for the type III secretion system
(T3SS) that delivers effector proteins. To identify unknown type III effectors in Bordetella, secreted proteins in the bacterial
culture supernatants of wild-type B. bronchiseptica and an isogenic T3SS-deficient mutant were compared with iTRAQ-
based, quantitative proteomic analysis method. BB1639, annotated as a hypothetical protein, was identified as a novel type
III secreted protein and was designated BspR (Bordetella secreted protein regulator). The virulence of a BspR mutant (DbspR)
in B. bronchiseptica was significantly attenuated in a mouse infection model. BspR was also highly conserved in B. pertussis
and B. parapertussis, suggesting that BspR is an essential virulence factor in these three Bordetella species. Interestingly, the
BspR-deficient strain showed hyper-secretion of T3SS-related proteins. Furthermore, T3SS-dependent host cell cytotoxicity
and hemolytic activity were also enhanced in the absence of BspR. By contrast, the expression of filamentous
hemagglutinin, pertactin, and adenylate cyclase toxin was completely abolished in the BspR-deficient strain. Finally, we
demonstrated that BspR is involved in the iron-responsive regulation of T3SS. Thus, Bordetella virulence factors are
coordinately but inversely controlled by BspR, which functions as a regulator in response to iron starvation.
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Introduction
Bordetella is a genus of gram-negative b-proteobacteria and is
currently divided into 9 species with different hosts [1]. Bordetella
pertussis, B. parapertussis, and B. bronchiseptica are highly genetically
related pathogens that cause respiratory diseases in animals. B.
parapertussis can be divided into two distinct lineages, B. para-
pertussisHU and B. parapertussisOV, which infect human and sheep,
respectively. [2]. B. pertussis and B. parapertussisHU are strictly
human-adapted species and are the etiological agents of whooping
cough (pertussis) [3]. B. bronchiseptica is a pathogen with a broad
range of hosts and causes chronic infections: kennel cough in dogs,
snuffles in rabbits, and atrophic rhinitis in swine [4]. Despite
differences in host tropism, these three Bordetella species share
many virulence factors and a control system for virulence [5].
A virulence-associated two-component signal transduction
system composed of BvgA and BvgS (BvgAS) serves as the master
regulator for most Bordetella virulence factors [6]. BvgS is a
transmembrane sensor kinase, and BvgA is a DNA-binding
responsive activator [7]. At 37uC in standard Bordetella medium,
BvgS is autophosphorylated and eventually transfers the phos-
phate group to BvgA via an intramolecular, four-step phospho-
relay cascade (designated as Bvg
+ phase) [8]. Phosphorylated BvgA
is then activated and binds DNA to promote the transcription of
various virulence genes including adhesins, toxins, and the
components of the type III secretion system (T3SS) [9]. The
BvgAS system is environmentally responsive and two other Bvg-
regulated phases have been characterized [10,11,12]. In contrast
to Bvg
+ phase, expression of Bvg-activated genes were repressed
when the bacteria grown at 37uC in medium containing high
concentrations of MgSO4 (Bvg
- phase). Growth at 37uCi n
medium containing ‘semi-modulating’ concentrations of MgSO4
allows the Bvg-intermediate (Bvg
i phase). Thus, the BvgAS system
plays a key role in the virulent phase of Bordetella species [13].
Many gram-negative pathogens produce a T3SS, which has a
needle-like structure protruding from the bacterial outer mem-
brane and delivers effectors into host cells, thereby altering the
physiological functions of infected cells [14]. Five type III secreted
proteins, BteA (also referred to as BopC), BopB, BopD, BopN, and
Bsp22, have been identified in Bordetella [15,16,17]. BopB and
BopD form a translocation pore complex in the host membrane
that acts as a conduit for effectors [15,17]. Bsp22 forms a
filamentous structure at the tip of the needle structure and
associates with the pore component BopD [16]. Two type III
effectors, BteA and BopN, have been identified in Bordetella
[18,19,20]. BteA is localized to lipid rafts in host cells via its N-
terminal region and induces necrotic cell death in various types of
mammalian cells [18,20]. BopN is translocated into the nucleus
and alters the nuclear translocation of NF-kB, resulting in the up-
regulation of IL-10, an anti-inflammatory cytokine [19].
The T3SS-related gene cluster, the bsc locus, is highly conserved
among B. pertussis, B. parapertussis, and B. bronchiseptica [3]. The bsc
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components, regulators, and secreted proteins; the gene encoding
BteA is separated from the bsc locus [18,20,21]. The btr locus is
adjacent to the bsc locus and encodes BtrS, BtrU, BtrW, and BtrV,
which are involved in the regulation of T3SS-associated genes at
the transcriptional or post-transcriptional level [22,23]. BtrS is an
extracytoplasmic function (ECF) sigma factor that is positively
regulated by BvgAS and is necessary for the transcriptional
activation of T3SS-associated genes including bsc, btr, and bteA
[23].
To further explore the function of the Bordetella T3SS, we
searched for unknown substrates of the T3SS in B. bronchiseptica
using an iTRAQ-based comparative proteomic approach and
identified a novel type III secreted protein, BspR. Here, we report
that BspR is involved in the regulation of various BvgAS-regulated
genes encoding the T3SS, filamentous hemagglutinin, pertactin,
and adenylate cyclase toxin.
Results
BB1639 is Secreted by the T3SS in B. bronchiseptica
To identify novel type III secreted proteins in B. bronchiseptica,w e
performed an iTRAQ-based proteomic analysis to compare the
secretion profiles of a wild-type B. bronchiseptica strain and an
isogenic mutant lacking a functional T3SS (DT3SS: bscN mutant)
(Fig. 1). The total proteins recovered from each bacterial culture
supernatant (Fig. S1) was labeled with iTRAQ reagents and
subjected to tandem mass spectrometry (MS/MS) analysis, which
determines the quantitative differences in the levels of peptides and
proteins from distinct sources. The peak ratio of wild-type signal to
DT3SS signal for each individual identified protein was calculated
by analyzing the peak area of the released reporter peptide from
the iTRAQ tag during MS/MS. As expected, the previously
characterized type III secreted proteins BopB, BopD, BopN, BscF,
Bsp22, and BteA were identified in the wild-type supernatant at a
significantly higher level than in the DT3SS supernatant (Table 1).
On the other hand, the peak ratios of T3SS-independent secreted
proteins in the wild-type sample were similar to those in the
DT3SS sample (0.72- to 1.70-fold) (Table 1). Interestingly, the
peak ratio of an uncharacterized open reading frame (BB1639,
NP_888184) was higher in the wild-type strain than that in the
DT3SS strain (by 3.85-fold), suggesting that BB1639 is a candidate
T3SS-dependent secreted protein. BB1639 is a hypothetical
protein encoded in the btr locus and is located directly upstream
of btrS (Fig. 1A). BB1639 is highly conserved in the btr loci of B.
pertussis (BP2233, NP_880877) and B. parapertussis (BPP2242,
NP_884492) (Fig. 1B), but the function of this gene in each
species remains to be elucidated. In this study, we propose that the
product of BB1639 be renamed BspR (Bordetella secreted protein
regulator). We also detected BscF that is thought to be a
component of the needle structure of the T3SS [3]. BscF was
eliminated from further study, since the needle structures have
been characterized in several T3SS-related pathogens [24].
To confirm that BspR is secreted via the T3SS, we performed
immunoblot analysis using anti-BspR antibodies (Fig. 1C). Intra-
cellular BspR was detected in whole-cell lysates of both wild-type
and DT3SS B. bronchiseptica. By contrast, the secretion of BspR into
bacterial culture supernatants was only detected in the wild type
strain and not in the DT3SS strain. B. bronchiseptica cultured in the
presence of MgSO4 was shifted into the avirulent phase, which
inhibited the secretion most virulence proteins including the type
III secreted proteins. As expected, intracellular and secreted BspR
were no longer detected in either the wild-type strain or the
DT3SS strain in the presence of MgSO4. These results clearly
indicate that BspR is a type III secreted protein and is expressed
under the control of the BvgAS system.
BspR Negatively Regulates the T3SS in B. bronchiseptica
When B. bronchiseptica was grown in liquid SS medium, a
number of virulence factors, such as adhesins, toxins, and type III
secreted proteins, were detected in the bacterial culture superna-
tants [15]. To investigate the role of BspR in protein secretion,
wild-type, T3SS mutant (DT3SS), bspR mutant (DbspR), and bspR-
complemented (DbspR/pbspR) B. bronchiseptica strains were each
cultured in SS medium for 18 h. The secreted proteins were
isolated from each bacterial culture supernatant and subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) followed by Coomassie brilliant blue (CBB) staining
(Fig. 2A). Secreted protein prepared from a culture containing
MgSO4 was used as a negative control. The type III secreted
proteins BteA, BopB, BopD, BopN, and Bsp22 were detected in
culture supernatant from the wild-type strain but not those from
the DT3SS strain. Interestingly, the secretion of the type III-
associated proteins was greatly increased in the DbspR strain. By
contrast, the secretion profile of a complemented strain (DbspR/
pbspR) was similar to that of the wild-type strain. To further
investigate the effect of BspR on the T3SS, whole bacterial lysates
were analyzed by immunoblotting (Fig. 2B). Again, the amount of
type III secreted proteins (BopB, BopD, BopN, BteA, and Bsp22)
in whole DbspR cells was greater than that in wild-type and DbspR/
pbspR cells. These results suggest that BspR negatively regulates
the secretion of type III secreted proteins into the bacterial culture
supernatant.
To determine whether BspR regulates the expression of genes
encoding type III secreted proteins at the transcriptional level,
total RNA was isolated from B. bronchiseptica, and cDNA was
reverse transcribed from the total RNA for qRT-PCR analysis
(Fig. 2C). The relative amounts of bsp22, bopN, and bteA mRNA in
the DbspR strain were approximately 8-fold greater than those in
the wild-type strain. Interestingly, the btrS mRNA level in the
DbspR strain was also significantly higher than that in the wild-type
strain. Again, there are no significant differences in the relative
amounts of mRNA between the wild-type and DbspR/pbspR
strains. Collectively, these results indicate that BspR functions as a
negative regulator of type III secreted proteins at the transcrip-
tional level.
A BspR-deficient Strain is Hyper-virulent in Cultured
Mammalian Cells
B. bronchiseptica infection induces necrotic cell death in various
cultured mammalian cells, and this activity is dependent on the
translocation of the BteA effector into host cells [18,20]. To
determine whether BspR affects T3SS-dependent cytotoxicity, L2
cells were infected with wild-type, DT3SS, DbspR or DbspR/pbspR
B. bronchiseptica and stained with Giemsa solution to analyze cell
morphology under a light microscope (Fig. 3A). Approximately
60–70% of cells infected with wild-type or DbspR/pbspR B.
bronchiseptica were detached from the substratum, and the
remainder of the adherent cells exhibited shrunken cytoplasm
and condensed nuclei (Fig. 3A). The L2 cells exposed to the
DT3SS strain showed normal morphology, similar to uninfected
cells. By contrast, more than 90% of cells infected with the DbspR
strain were detached, and the morphological changes observed
were more severe than those in the wild-type or DbspR/pbspR
strain. To quantify T3SS-dependent cytotoxicity, the relative
amount of LDH released into the extracellular medium was
measured (Fig. 3B). When the cells were infected with wild-type or
DbspR/pbspR B. bronchiseptica, LDH release progressively increased
BspR Regulates Virulence Genes
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after infection. By contrast, the cytotoxicity of the DbspR strain was
significantly greater than that of the wild-type strain.
B. bronchiseptica induces the hemolysis of rabbit red blood cells
(RBCs) in an adenylate cyclase toxin (CyaA)- or T3SS-dependent
manner. In particular, T3SS-dependent hemolysis is caused by the
formation of the pore complex containing BopB and BopD in the
RBC plasma membrane, which results in membrane disruption
[15,16,17]. In a previous report, we established a system to
measure T3SS-dependent hemolytic activity [15]. To investigate
whether BspR is involved in T3SS-dependent hemolysis, rabbit
RBCs were exposed to B. bronchiseptica (Fig. 3C). The hemolytic
activity of the wild-type strain was 27.8% of a Triton X-100-
treated positive control. Again, the hemolytic activity of the DbspR
strain was 85.5%, significantly higher than that of the wild-type
strain. Taken together, the absence of BspR results in the de-
repression of the T3SS, leading to enhanced T3SS-dependent
phenotypes in cultured mammalian cells.
The bspR-deficient strain showed characteristic features includ-
ing a hyper-secretion phenotype for type III secreted proteins
(Fig. 3). Hyper-secretion resulted in the enhancement of T3SS-
dependent cytotoxicity and hemolysis in cultured mammalian cells
(Fig. 3A, B, and C), suggesting that the DbspR strain has been
shifted into a hyper-virulent state. For this reason, C57BL/6J mice
were infected intranasally with wild-type or DbspR B. bronchiseptica
(Fig. 3D). Although 80% of mice infected with the wild-type strain
succumbed within 5 days after infection, all mice infected with the
DbspR strain survived. Thus, the virulence of the DbspR strain was
clearly attenuated relative to that of the wild-type strain (Fig. 3D).
The attenuation of virulence in the DbspR strain is probably
attributable to dysregulation of the T3SS.
BspR Globally Regulates Virulence Genes in
B. bronchiseptica
In this study, we demonstrated that the bspR-deficient strain
shows enhanced production of type III secreted proteins. By
contrast, some protein bands disappeared in the absence of BspR
(Fig. 2A, arrowheads). Those bands were detected in the DT3SS
strain but not in wild-type culture under MgSO4-replete
conditions. These findings suggest that other T3SS-independent
secreted proteins are oppositely regulated by BspR. Therefore,
we decided to investigate the effect of BspR on the production of
T3SS-independent virulence factors by immunoblot analysis
(Fig. 4A). Filamentous hemagglutinin (FhaB), pertactin (Prn),
and CyaA were detected in both whole-cell lysates and bacterial
supernatants of the wild-type strain or the DbspR/pbspR strain.
However, these bands completely disappeared in the DbspR
strain. By contrast, the production and secretion of dermone-
crotic toxin (DNT) were not affected by the bspR mutation. To
further investigate whether the reduced expression of FhaB and
Prn in the DbspR strain occurred at the transcriptional level, total
RNA was isolated from B. bronchiseptica and analyzed by qRT-
PCR to quantify the relative amounts of fhaB and prn mRNAs
Figure 1. BspR is a type III secreted protein conserved in pathogenic Bordetella species. (A) Genomic organization of the bsc and btr loci in
B. bronchiseptica. Sequence data were obtained from the B. bronchiseptica sequencing group at the Sanger Institute (ftp://ftp.sanger.ac.uk/pub/
pathology/bb/). (B) BLAST alignment of BspR: BB1639 in B. bronchiseptica (Bbr), BPP2242 in B. parapertussis (Bpp), and BP2233 in B. pertussis (Bpe). The
dots represent identical amino acid sequence in their respective Bordetella spp. The asterisk indicates the putative start methionine codon predicted
by MetaGeneAnnotator (http://metagene.cb.k.u-tokyo.ac.jp/). (C) Immunoblot analysis using anti-BspR antibodies. Wild-type and DT3SS
B. bronchiseptica were grown on SS medium in the absence or presence of MgSO4 under vigorous shaking at 37uC for 18 h. Whole-cell lysates
(WCL) and secreted protein fraction in the supernatant (Sup) were prepared from the bacterial cultures and analyzed by immunoblot analysis using
anti-BspR antibodies. The arrowhead indicates the specific signal for BspR.
doi:10.1371/journal.pone.0038925.g001
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bronchiseptica grown under MgSO4-depleted conditions, in which
the BvgAS system is active. By contrast, the relative amount of
fhaB or prn mRNA in the DbspR strain was lower than that in the
wild-type and DbspR/pbspR strains. Collectively, BspR is involved
in regulation of type III secreted proteins and other virulence
factors.
BspR Regulates Virulence Factors in Response to Iron
Starvation
A recent study revealed that iron starvation induces the up-
regulation of the T3SS [25]. Thus, the phenotypes exhibited by
B. bronchiseptica under iron-starvation conditions appear to be
similar to those of the bspR-deficient strain. To investigate the role
of BspR under conditions of iron starvation, wild-type, DbspR, and
DbspR/pbspR B. bronchiseptica strains were grown in SS medium
supplemented with iron at a final concentration of 0, 36, or
360 mM. Then, the secreted proteins in the bacterial culture
supernatants were subjected to SDS-PAGE (Fig. 5). The secretion
of type III–associated proteins by the wild-type strain was fully
promoted in the absence of iron and gradually decreased in
response to increasing iron concentration. To our surprise, the
deletion of BspR completely abolished the iron-responsive
regulation of the T3SS. The hyper-secretion of type III secreted
proteins by the DbspR strain was detected even with high iron
concentrations. By contrast, the phenotype of the DbspR/pbspR
complemented strain was similar to that of the wild-type strain.
These results suggest that BspR regulates the expression of the
T3SS in response to the iron concentration.
BspR Functions as a Global Regulator in B. bronchiseptica
These findings led to our hypothesis that BspR may play a role
in a global regulator. For this reason, total proteins included in
whole-cell lysate from wild-type or DbspR was labeled with iTRAQ
reagents and subjected to MS/MS analysis. The peak ratio of
DbspR signal to wild-type signal for each individual identified
protein was calculated and resulting data were presented in the
rank order of the 18 most abundant proteins (Table 2) and the 18
least amounts of proteins (Table 3). The raw data are also
presented in Table S1. For example, recombination-associated
protein PdgC and transcriptional termination factor Rho are
dramatically increased in the bspR mutant strain (Table 2). In
contrast, biotin carboxyl carrier protein FabE and diaminobuty-
rate aminotransferase EctB are reduced in the bspR mutant strain
(Table 3). These results strongly suggest that BspR functions as a
global regulator in B. bronchiseptica.
Discussion
In this study, we performed comparative profiling of the
proteins secreted by B. bronchiseptica and characterized a hypothet-
ical protein, BB1639, as a novel type III secreted protein, BspR.
Alignment of BspR showed different N-terminal sequences among
Bordetella species (Fig. 1B). The theoretical size of BspR in
B. bronchiseptica was 24.7 kDa (226 amino acids) [3]. By contrast,
the theoretical size of BspR was 25.0 kDa (232 amino acids) in
B. pertussis and B. parapertussis. Unexpectedly, the immunoblot
analysis showed that the actual size of BspR was approximately
20 kDa (Fig. 1C). We also confirmed that a 20-kDa BspR species
was detected in the whole-cell lysates and supernatants of the
B. pertussis Tohama I strain and several clinical isolates of B.
pertussis (data not shown). For this reason, we analyzed annotated
sequence of BB1639 by MetaGeneAnnotator (http://metagene.
cb.k.u-tokyo.ac.jp/) that is able to predict the ribosome-binding
site of prokaryotic genes [26]. This program assigned the BB1639
open reading frame of 191 amino acids, but not 226 amino acids.
Taken together, these results suggest that BspR is probably
20.4 kDa (191 amino acids), with the start codon at amino acid 36
of the originally annotated sequence (denoted by the asterisk in
Fig. 1B).
In this study, we complemented the bspR mutant strain by the
fhaB promoter-driven bspR expression vector. The fhaB promoter-
driven vector produces certain amount of BspR that allows
effective complementation of the bspR mutant. To exclude the
unexpected feed back effect on fhaB promoter by produced BspR,
we also confirmed that DbspR was complemented by the bspR
expression vector with its own promoter (Fig. S2).
The lack of BspR resulted in the increased expression of the
T3SS, leading to enhancement of T3SS-dependent cytotoxicity
and hemolysis in cultured mammalian cells (Fig. 2A, B, and C).
Therefore, DbspR appears to be shifted in the hyper-virulent strain.
However, in vivo infection demonstrated that the virulence of the
DbspR strain was attenuated relative to that of wild-type strain
(Fig. 3D). We reasoned that attenuated virulence of the DbspR
strain can be attributed to dysregulation of virulence factors, such
as FhaB and CyaA (Fig. 4). Indeed, b-hemolytic activity observed
in the BG agar plate is poorly detected in DbspR strain and this
activity is dependent on the CyaA, but not the T3SS (data not
shown). Furthermore, whole-cell proteome analysis clearly indi-
cates that BspR affects expression of various types of bacterial
proteins (Table 2, 3, and S1). These findings suggest that the
Table 1. T3SS -dependent and -independent secreted





Bsp22 type III needle tip protein T3SS 7.94 ,0.01
BteA type III effector T3SS 7.52 ,0.01
BopB type III translocator T3SS 5.88 ,0.01
BopD type III translocator T3SS 5.52 ,0.01
BscF type III needle monomer T3SS 5.03 ,0.01





BB3110 putative autotranporter T5SS 1.70 ,0.01
CyaA adenylate cyclase toxin/
hemolysin
T1SS 1.48 ,0.01
FhaS homologue of FhaB T5SS 1.46 ,0.01
BapC autotransporter T5SS 1.23 ,0.01
FhaL homologue of FhaB T5SS 1.13 0.01
BapB autotransporter T5SS 1.11 0.04
Prn adhesion factor T5SS 1.04 0.02
BipB putative adhesion factor T5SS 0.92 ,0.01
FhaB adhesion factor T5SS 0.91 0.01
FimB chaperone protein T2SS 0.72 ,0.01
1Ratio of the amount of secreted protein of wild-type B. bronchiseptica against
DT3SS strain.
2Significance in the differences between wild type and DT3SS (t-test).
doi:10.1371/journal.pone.0038925.t001
BspR Regulates Virulence Genes
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38925coordinate expression of virulence and non-virulence genes are
required for the systemic infection of B. bronchiseptica.
The bacterial transcription initiation is regulated by the sigma
factor, which associates with the catalytic core RNA polymerase
(RNAP) to form the holoenzyme [27,28]. All bacteria possess at
least one essential sigma factor, and alternative sigma factors are
involved in the specific gene expression in response to the
environmental conditions. In addition, the activity and availability
of sigma factors are controlled, in part, by anti-sigma factors that
bind and repress their cognate sigma factor. To date, the sigma
factor-28 (s
28) and anti-sigma factor (FlgM) interaction is the most
extensively characterized in several bacteria and both factors are
involved in the regulation of the bacteria flagellum assembly [27].
The crystal structure of the s
28/FlgM complex revealed that a
single FlgM composed of three a-helices wraps around a compact
s
28 molecule [29]. As a result, FlgM sterically occludes the RNAP-
binding determinants of s
28 and stabilizes extensive interdomain
interactions within s
28 that mask the promoter-binding determi-
nants of s
28 [29]. The bspR is located directly upstream of btrS,
whose product activates the expression of T3SS genes in the
BvgAS-activated phase [23]. BtrS belongs to a family of ECF
sigma factors [22,23], but analysis of deletion mutants of BtrW and
BtrV revealed that neither is involved in the expression of T3SS
genes, nor do they contribute to the post-transcriptional regulation
of the T3SS (i.e., intracellular stability and secretion). Thus, anti-
sigma factor for BtrS has not been identified in Bordetella species
[23] and BspR does not show any sequence similarity to previously
described anti sigma factors or regulators. Furthermore, we carried
out the GST-pull down assay, but we failed to detect interaction
between BspR and BtrS sigma factor (data not shown).
In this study, we demonstrated that BspR functions as a
regulator of various genes (Fig. 2, Table 2 and 3). We also found
that the btrS expression was induced by the DbspR strain (Fig. 3C)
and similar results were obtained by the whole-cell proteome
analysis (The DbspR:wild type ratio=4.17; Table S1). In addition,
the endogenous bspR expression was repressed by the introduction
of the FLAG-tagged bspR expression vector into B. bronchiseptica
wild type (data not shown), suggesting that BspR negatively
regulates its own gene on the btr locus.
To our surprise, the relative amount of BvgA in the DbspR was
significantly higher that in B. bronchiseptica wild type (Table 2).
Although the precise mechanism of the BvgA regulation by BspR
remains to be elucidated, BspR may functions as a molecular
switch via alteration of the BvgA concentration. Indeed, previous
report of BipA in B. pertussis indicates that the BvgA concentration
has the critical role in the alteration of the Bvg-regulated phases
[30]. The bipA encodes a large outermembrane protein with
similarity to intimin of enteropathogenic Echerichia coli and invasin
of Yersinia spp. [31], and is maximally expressed in the Bvg
i phase
[30]. The in vitro transcription assay clearly demonstrated that
BvgA functions as both positive and negative regulators for the
bipA transcription in the Bvg
i phase expression [30]. It has been
also reported that the bipA promoter region was incubated with
RNA polymerase (RNAP) in the various concentrations of BvgA-
Figure 2. BspR negatively regulates the expression of T3SS-associated genes. B. bronchiseptica strains were grown in SS medium under
vigorous shaking at 37uC. The wild-type strain cultured in the presence of MgSO4 (40 mM) was used as a negative control. (A) The secreted proteins
isolated from bacterial culture supernatants were separated by SDS-PAGE and stained with CBB. Arrows indicate the bands corresponding to type III
secreted proteins: A, BteA (multimerized); B, BopB; N, BopN; D, BopD; and 22, Bsp22. Arrowheads indicate the bands that disappeared in the absence
of BspR. (B) Whole bacterial lysates were prepared from bacterial cultures and analyzed by immunoblotting using the following antibodies: anti-BspR,
anti-BteA, anti-BopB, anti-BopN, anti-BopD, and anti-Bsp22. (C) Total RNA isolated from B. bronchiseptica strains was subjected to quantitative RT-PCR
analysis. The graphs show the relative amounts of bsp22, bopN, bteA, and btrS mRNA normalized to the mRNA for the housekeeping gene recA. The
wild-type strain cultured in the presence of MgSO4 (40 mM) was used as a negative control. The values represent the means 6 SE from three
independent experiments. ***, P,0.001.
doi:10.1371/journal.pone.0038925.g002
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was induced at concentrations of BvgA,P between 20 and
220 nM [30]. In contrast, the transcriptional activity was reduced
at concentrations of BvgA,P between 220 and 600 nM. Thus,
relatively low concentrations of BvgA,P are required for
activation of bipA trancription. Similar results were also obtained
by our proteome analysis. The BipA expression was significantly
decreased in the bspR mutation (Table 3), where the abundance of
BvgA was significantly increased. In Bordetella species, the BvgAS
system functions as a master regulator of the various gene
expression icluding btrS on the btr locus (Table 2). Collectively,
these results suggest that BspR regulates btrS and other gene
expressions via the alteration of the BvgA concentration, rather
than the anti sigma factor for BtrS.
Secreted regulators have been reported in some bacterial
species. ExsE is a protein secreted via the T3SS in Pseudomonas
aeruginosa and has the ability to bind to an anti-anti-activator,
ExsC, before secretion [32,33]. The decrease in intracellular ExsE
levels caused by its secretion results in the release of ExsC. The
released form of ExsC associates with ExsD, resulting in
the disruption of the ExsD-ExsA complex. Finally, liberating the
transcriptional activator ExsA promotes the transcription of
the Pseudomonas T3SS operon. Vp1702 in Vibrio parahaemolyticus
has no sequence similarity with ExsE, but deletion of Vp1702
results in the enhanced secretion of type III-associated proteins,
and Vp1702 itself is secreted via the T3SS in V. parahaemolyticus
[34]. Thus, the secretion of a negative regulator via the T3SS may
be a common strategy for the regulation of T3SSs among various
bacterial species. One striking feature of BspR is its role as a
secreted regulator of iron-responsive virulence genes.
The transcription of most iron-responsive genes is controlled
by the ferric uptake regulator (Fur) protein [35]. Under iron-
replete conditions, the iron-bound form of Fur directly binds to
the consensus sequence in the upstream of target genes (e.g.,
those encoding iron acquisition systems) to repress their
transcription [36]. Although the Bordetella T3SS is also controlled
by the iron concentration, a typical Fur binding site has not been
found in the intergenic region upstream of the bsc or btr locus
[25]. In this study, we found that the phenotype of iron-starved
wild-type B. bronchiseptica, including the hyper-secretion of type
III-associated proteins, was similar to that of the DbspR strain.
Furthermore, the secretion of type III-associated proteins
decreased in response to an increase in the iron concentration,
but this stringent regulation was relieved in the absence of BspR.
Thus, BspR is involved in the iron-responsive gene expression of
virulence factors.
Figure 3. A BspR-deficient strain is hyper-virulent against cultured mammalian cells. (A) L2 cells were infected with the indicated B.
bronchiseptica strains at an MOI of 20 for 20 min. Infected cells were subjected to Giemsa staining and were analyzed under a light microscope. (B)
HeLa cells were infected with the indicated B. bronchiseptica strains at an MOI of 10. The amount of LDH released into the extracellular medium from
infected cells was quantified at 0, 60, 120, and 180 min post-infection, and the relative cytotoxicity (%) was determined as described in the Materials
and Methods section. The data for each sample are presented as the mean 6 SE of three independent experiments. ***, P,0.001. (C) RBCs were
tightly pelleted with the indicated B. bronchiseptica strains by centrifugation and incubated for 30 min. After incubation, the release of hemoglobin
from the RBCs into the extracellular buffer was calculated by measuring the absorbance at 492 nm. The presented values are percentages of Triton X-
100-lysed RBCs after subtraction of the measured lysis of untreated cells. The data for each sample are presented as the mean 6 SE of three
independent experiments. *, P,0.05; NS, no significance. (D) C57BL/6J mice were infected intranasally (5610
6 CFU/mouse) with a wild-type or DbspR
strain. The survival of the mice (n=4 per group) was monitored for 8 days after infection. *, P,0.05 using the log-rank test.
doi:10.1371/journal.pone.0038925.g003
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in several gram-negative bacteria. Over-production of ExsA results
in the reduction of flagellar gene expression and motility in
P. aeruginosa [37]. Conversely, both a P. aeruginosa mutant lacking
the flagellar filament and a mutant deficient for GacA, which is a
positive regulator of motility, show hyper-secretion of ExoS, a
T3SS effector [37]. In Bordetella, the motility and synthesis of
flagella are negatively regulated by the BvgAS system [38],
indicating that the T3SS and flagella are inversely regulated in
Bordetella species. In this study, we speculate that BspR may
function as a molecular switch by alteration of the BvgA
concentration and the absence of iron is an environmental cue
for the host internalization. Our data suggest that virulence factors
are coordinately and inversely regulated by BspR, depending on
the bacterial infection stage. The precise molecular mechanism of
the effect of BspR on virulence gene expression under iron
starvation or iron-rich conditions remains to be elucidated. The
model of BspR-mediated gene regulation provides new insight into




This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the Ministry of Education, Culture, Sports,
Science and Technology of Japan and Social Council of Japan.
The protocol was approved by the Committee on the Ethics of
Animal Experiments of Kitasato University (Permit Number:
11014). All surgery was performed under sodium pentobarbital
anesthesia, and all efforts were made to minimize suffering.
Bacterial Strains, Cell Culture and Growth Media
The wild-type strain used in this study was Bordetella
bronchiseptica S798 [15]. The isogenic type III secretion mutant
(DT3SS), which is deficient in bscN ATPase for the type III
secretion, was derived from S798 [15]. Bordetella strains were
cultured in Stainer and Scholte (SS) medium with a starting A600
of 0.2 under vigorous shaking at 37uC, and the inoculum was
prepared from fresh colonies grown on Bordet and Gengou (BG)
agar as described previously [39,40,41]. The wild-type B.
bronchiseptica grown in SS medium containing MgSO4 at a final
concentration of 40 mM was used as a negative control in this
study because of the inactivation of BvgAS-regulated virulence
genes [9]. The liquid cultivation period was 18 h for the protein
Figure 4. BspR affects the expression of adhesins and toxins in
B. bronchiseptica. B. bronchiseptica strains were grown in SS medium
under vigorous shaking at 37uC for 18 h (for immunoblotting) or 9 h
(for RT-PCR analysis). The wild-type strain cultured in the presence of
MgSO4 (40 mM) was used as a negative control. (A) A whole-cell lysates
(WCL) and a fraction containing secreted proteins in the supernatant
(Sup) were prepared from each bacterial culture and analyzed by
immunoblotting using the following antibodies: anti-FhaB, anti-CyaA,
anti-Prn, and anti-DNT. (B) Total RNA prepared from B. bronchiseptica
strains was subjected to quantitative RT-PCR analysis. The graphs show
the relative amounts of fhaB and prn mRNA normalized to the amount
of mRNA for the housekeeping gene recA. The values are the means 6
SE from three independent experiments. *, P,0.05; ***, P,0.001.
doi:10.1371/journal.pone.0038925.g004
Figure 5. Signaling under iron starvation conditions is
dysregulated in the absence of BspR. Wild-type, DbspR, and
DbspR/pbspR B. bronchiseptica strains were grown in SS medium
supplemented with iron at a final concentration of 0, 36, or 360 mM. The
standard SS medium commonly used elsewhere contains iron at a
concentration of 36 mM. The secreted proteins isolated from bacterial
culture supernatants were separated by SDS-PAGE and stained with
CBB. Arrows indicate the bands corresponding to the type III secreted
proteins BteA (multimerized), BopB, BopN, BopD, and Bsp22 (A, B, N, D,
and 22, respectively).
doi:10.1371/journal.pone.0038925.g005
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preparation. L2 (ATCC CCL-149) and HeLa (ATCC CCL-2)
cells were maintained in F-12K (Invitrogen) and Eagle’s
minimum essential medium (EMEM) (Sigma), respectively, each
containing 10% fetal calf serum at 37uC under an atmosphere of
5% CO2.
Proteomic Analysis Using iTRAQ Reagents and Tandem
Mass Spectroscopy
Bacteria were cultured in SS medium at 37uC under vigorous
shaking for 18 h as described above. To prepare the total
secreted protein samples, the culture supernatants of wild-type
and DT3SS B. bronchiseptica were centrifuged followed by
filtration. The clarified supernatants were concentrated by
ultrafiltration using Centriprep columns with a 10,000 nominal
molecular weight limit (Millipore) and were reconstituted with
PBS. The proteins were denatured with SDS, reduced with
Tris(2-carboxyethyl)phosphine (TCEP), alkylated with methyl
methanethiosulfonate (MMTS), and then digested with trypsin
(Applied Biosystems) at 37uC for 18 h. The resulting peptides
derived from the proteins secreted by wild-type and DT3SS B.
bronchiseptica were labeled with the 116 and 119 iTRAQ tags
(Applied Biosystems), respectively. The labeled peptides were
mixed, followed by fractionation using strong cation exchange
(SCX) chromatography (Cation Exchange Buffer Pack, Applied
Biosystems). Each fraction was subjected to mass spectrometry
analysis using a QSTAR Elite Hybrid LC/MS/MS System
(Applied Biosystems) and a DiNa System (KYA TECH Corp.).
The MS-MS spectrum data were processed using Protein Pilot
TM
Software 2.0.1 (Applied Biosystems), with the Paragon algorithm
[42] by comparison with the genomic database for B.
bronchiseptica RB50. Protein identification was performed with a
confidence threshold of a Protein Pilot
TM Unused Score .2.0.
The heights of the iTRAQ reporter ion peak in the MS/MS
spectra were also calculated by Protein Pilot
TM to determine the
ratio relative to the reporter. For the analysis of the protein
profile of whole-cell lysate, wild-type or DbspR B. bronchiseptica was
cultured in SS medium at 37uC under vigorous shaking for 18 h
as described above. The bacterial culture was centrifuged to be
precipitated and resuspended with B-PER (Piece) to be lysed.
The crude bacterial lysate was clarified by centrifugation and was
processed to be trypsinized as described above. The resulting
peptides derived from the whole-cell lysates of wild-type and
DbspR B. bronchiseptica were labeled with the 114 and 117 iTRAQ
tags (Applied Biosystems), respectively. The labeled peptides were
subjected to the mass spectrometry analysis. As described above,
the resulting MS/MS spectra was processed by comparison with
the genomic database for B. bronchiseptica RB50, B. pertussis
Tohama I, and B. parapertussis 12822 for the protein identifica-
tions.
Primers
The primers used in this study are listed in Table 4.
Construction of the bspR Mutant
pDONR221 (Invitrogen) and pABB-CRS2 [43] were used as
cloning and positive suicide vectors, respectively. A 2.6-kbp DNA
fragment containing the bspR gene and its flanking region was
amplified by PCR with the primers B1-bspR and B2-bspR using
B. bronchiseptica S798 genomic DNA as the template. The resulting
PCR product was cloned into pDONR221 using the adaptor PCR
method (Gateway cloning system, Invitrogen) to obtain pDONR-
bspR. Then, for the deletion of bspR in pDONR-bspR, inverse PCR
was carried out with the primers R1-bspR and R2-bspR using
circular pDONR-bspR as a template. The resulting PCR products
Table 2. Increased proteins by the bspR deletion.
Protein Description
1DbspR:WT
RdgC recombination-associated protein 30.48
Rho transcription termination factor 28.58
Alr alanine racemase 26.55
FtsA cell division protein 26.06
ParE DNA topoisomerase IV subunit B 25.59
BB1615 hypothetical protein 21.09
BB4395 hypothetical protein 20.14
Bcr4 bsc-encoded protein 19.77
BB4209 putative hydrolase 19.41
EffB electron transfer flavoprotein beta-subunit 18.88
BB3158 putative phage-related protein 18.03




BopN type III effector 16.60
BvgA transcriptional regulator 16.29
BcrH2 type III chaperone 15.56
BscJ putative type III secreted protein 15.00
CydA cytochrome D ubiquinol oxidase subunit I 14.59
1Ratio of the amount of whole cell lysate proteins of DbspR against wild-type
B. bronchiseptica. P-value ,0.05.
doi:10.1371/journal.pone.0038925.t002
Table 3. Decreased proteins by the bspR deletion.
Protein Description
1DbspR:WT
FabE acetyl-CoA carboxylase biotin carboxyl carrier protein 0.02
EctB diaminobutyrate transaminase 0.03
BB2875 universal stress family protein 0.04
BB4467 putative membrane protein 0.04
BB4284 putative membrane protein 0.04
BB3926 putative cytochrome 0.05
ModB molybdate-binding periplasmic protein precursor 0.08
BB2813 putative uncharacterized protein 0.10
AtpF ATP synthase subunit b 0.11




BipA outermembrane protein 0.14
BB3328 cytochrome C oxidase subunit 0.15
BB3101 putative oxidoreductase 0.15
PaaG enoyl-CoA hydratase 0.15
BatB autotransporter 0.16
ThiC phosphomethylpyrimidine synthase 0.16
Prn pertactin autotransporter 0.16
1Ratio of the amount of whole cell lysate proteins of DbspR against wild-type
B. bronchiseptica. P-value ,0.05.
doi:10.1371/journal.pone.0038925.t003
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DbspR, which contained a BamHI site in addition to a 579-bp
deletion including the start codon of bspR. pDONR-DbspR was
ligated with pABB-CRS2 to obtain pABB-CRS2-DbspR using the
Gateway cloning system. pABB-CRS2-DbspR was then introduced
into E. coli SM10lpir and was transconjugated into B. bronchiseptica
S798, as described previously [44]. The resulting mutant strain
was designated DbspR.
Construction of Plasmids for Bacterial Gene Expression
For the complementation of the bspR defect in DbspR/pbspR was
constructed as follows [18]. An 881-bp fragment encoding bspR
was amplified by PCR with B1-bspR comp and B2-bspR comp
primers using S798 genomic DNA as a template. The resulting
fragment was cloned into pDONR221, and this construct was
designated pDONR-bspR-comp. To express BspR in B. bronchi-
septica, pDONR-fhaP( fha promoter), pDONR-bspR-comp, and
pDONR-rrnB (rrnB terminator) were mixed and cloned into the
pRK415 R4-R3-F vector using the MultiSite Gateway system
(Invitrogen) to obtain pbspR. For the construction of the bspR
expression vector under the control of its own promoter, pDONR-
bspR-comp was cloned into pABB415 vector ([17]) to obtain
pABB415-bspR.
Immunoblot Analysis
The secreted proteins released into bacterial culture superna-
tants and bacterial whole-cell lysates were isolated by trichlor-
oacetic acid precipitation. The culture supernatants were filtered,
and the bacterial pellets were resuspended in distilled water.
Trichloroacetic acid was then added to the samples at a final
concentration of 10%. After incubation of the samples on ice for
15 min, they were centrifuged for 5 min. The resulting precipi-
tated proteins were neutralized with 2 M Tris-base and dissolved
in sample buffer. The protein samples were separated by SDS-
PAGE and analyzed by CBB staining or immunoblot analysis.
Antibodies
To prepare the anti-BspR antibodies, peptides corresponding to
the amino acid residues 136 to 153 of BspR
(CHDTGVSPDQISGTLRAT) were cross-linked with a carrier
protein by the cysteine residue at the N-terminus. The cross-linked
peptides were used to immunize rabbits. To obtain specific
immunoglobulin fractions, all antisera obtained were adsorbed to
the peptide immobilized on sepharose. The anti-BteA, anti-BopB,
anti-BopD, anti-Bsp22, anti-filamentous hemagglutinin (FhaB)
and anti-pertactin (Prn) antibodies used in this study have been
described previously [15,17,18,45]. The anti-adenylate cyclase
toxin (CyaA) antibodies were purchased from Santa Cruz
Biotechnology. The anti-TEM-1 b-lactamase antibodies were
purchased from QED bioscience Inc. The anti-dermonecrotic
toxin (DNT) antibodies were a gift from Yasuhiko Horiguchi.
mRNA Analysis by RT-PCR
The mRNA levels were measured by quantitative reverse-
transcription PCR (qRT-PCR). Bacterial total RNA was isolated
with the RNeasy Mini Kit (QIAGEN), and the RNA sample was
reverse-transcribed with Omniscript Reverse Transcriptase (QIA-
GEN) with random primers. The resulting cDNA was amplified
with SYBR Premix Ex Taq (TAKARA) with the following primer
pairs: 5-recA and 3-recA for recA, 5-bsp22 and 3-bsp22 for bsp22,
5-bopN and 3-bopN for bopN, 5-bteA and 3-bteA for bteA, 5-btrS
and 3-btrS for btrS, 5-fhaB and 3-fhaB for fhaB, and 5-prn and 3-
prn for prn. The expression of recA was used as an internal control.
The specificity of each primer set was checked by analyzing the
melting curves, and results were calculated using the comparative
cycle threshold method, in which the amount of bsp22, bopN, bteA,
btrS, fhaB,o rprn mRNA is normalized to the amount of recA
mRNA and reported as arbitrary units set to a value of 1 for the
wild-type strain.
Infection Assays
Morphological changes in infected cells was observed as
previously described [15], except that cells were infected at an
multiplicity of infection (MOI) of 20. L2 (ATCC CCL-149) cells
(1610
5) seeded on coverslips in 6-well plates were infected with
bacteria at an MOI of 20. The cells were then centrifuged for
5 min and incubated for 20 min at 37uC in an atmosphere of 5%
CO2. The cells were washed with phosphate-buffered saline (PBS)
and fixed in methanol. Fixed cells were stained with Giemsa
solution (Merck) and analyzed by microscopy (Axioplan 2
Imaging, Zeiss). To examine the release of lactate dehydrogenase
(LDH) from infected cells, 7.5610
4 HeLa (ATCC CCL-2) cells
seeded in 24-well plates were infected with bacteria at an MOI of
10. The cells were then centrifuged for 5 min and incubated at
37uC in an atmosphere of 5% CO2 for the indicated amount of
time. The amount of LDH was measured spectrophotometrically
using a Cyto-Tox 96 non-radioactive cytotoxicity assay kit
(Promega). The relative amount of LDH release (%) was
calculated as follows: experimental LDH activity/total LDH
activity6100. The total LDH activity was measured using cells
treated with 1% Triton X-100.
























*The underlined portions (GGATCC) indicate the BamHI site for the self-ligation
of the inverse PCR products in the construction of mutants.
doi:10.1371/journal.pone.0038925.t004
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The measurement of type III-dependent hemolytic activity was
carried out as described previously [15]. Briefly, bacterial pellets
from overnight cultures and rabbit red blood cells (RBCs) were
washed with PBS and adjusted to 5610
10 bacteria/ml and
3610
9 cells/ml, respectively. The suspensions were mixed
together (using 50-ml aliquots per suspension) in 96-well plates
and centrifuged for 5 min to promote close contact. The
combined suspensions were then incubated at 37uC for 30 min
in a CO2 incubator. An additional 100 ml of PBS was added to
the mixtures of bacteria and RBCs, and then the plates were
centrifuged again. The supernatants were transferred to new
plates, and the optical density was measured at 492 nm. In a
previous study, we confirmed that the hemolytic activity induced
by the adenylate cyclase toxin can be excluded using this
measurement system [15].
In vivo Infection of Mice
C57BL/6J mice (5 to 6 weeks old) were purchased from CLEA
Japan, Inc. After arrival, all mice were housed for 1 week before
experiments. Mice were infected intranasally with 50 ml
(5610
6 CFU) of a B. bronchiseptica suspension prepared from an
individually isolated colony on BG agar plates.
Statistical Analysis
Survival curves were generated by the Kaplan-Meier method,
and statistical analyses were performed using the log-rank test. The
statistical significance was assessed by Student’s t-tests. A P-value,
,0.05 was considered significant.
Supporting Information
Figure S1 Secreted proteins isolated from B. bronchi-
septica culture supernatants. Wild-type and DT3SS B.
bronchiseptica strains were grown in SS medium under vigorous
shaking at 37uC for 18 h. The secreted proteins isolated from
bacterial culture supernatants were separated by SDS-PAGE and
stained with CBB.
(TIF)
Figure S2 Complementation of the DbspR strain. The
fhaB promoter-driven expression vector of bspR,p bspR (lane 3),
bspR expression vector by its own promoter, pABB415-bspR (lane
4), or the empty vector of pRK415 (lane 5) was introduced into the
DbspR strain, respectively. Bordetella bronchiseptica wild type (lane 1),
DbspR (lane 2), and DbspR complemented strains (lanes 3 and 4)
were grown in SS medium under vigorous shaking at 37uC for
18 h. The secreted proteins isolated from bacterial culture
supernatants were separated by SDS-PAGE and stained with
CBB (lower panel). The whole-cell lysates were analyzed by
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